Neutrophil depletion blocks early collagen degradation in repairing cholestatic rat livers

American Journal of Pathology

Volumn 176, Issue 3, 2010, Pages 1271-1281

  Harty, Mark W ^a   Muratore, Christopher S ^a   Papa, Elaine F ^a   Gart, Michael S ^a   Ramm, Grant A ^b   Gregory, Stephen H ^a   Tracy Jr , Thomas F ^a  

^a BROWN UNIVERSITY   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGENASE 3; GELATINASE B; MATRIX METALLOPROTEINASE 14; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT OBSTRUCTION; BLOOD CELL COUNT; COLLAGEN DEGRADATION; CONTROLLED STUDY; DECOMPRESSION SURGERY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME RELEASE; FIBROSIS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; MALE; MORPHOMETRICS; NEUTROPHIL; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

EID: 77749264268     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090527     Document Type: Article

References (35)

1. Tracy TF Jr, Goerke ME, Bailey PV, Sotelo-Avila C, Weber TR: Growth-related gene expression in early cholestatic liver injury. Surgery 1993, 114:532-537
2. Slott PA, Liu MH, Tavoloni N: Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 1990, 99:466-477
3. Roggin KK, Kim JC, Kurkchubasche AG, Papa EF, Vezeridis AM, Tracy TF: Macrophage phenotype during cholestatic injury and repair: the persistent inflammatory response. J Pediatr Surg 2001, 36:220-228
4. Saito JM, Maher JJ: Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. Gastroenterology 2000, 118:1157-1168
5. Saito JM, Bostick MK, Campe CB, Xu J, Maher JJ: Infiltrating neutrophils in bile duct-ligated livers do not promote hepatic fibrosis. Hepatol Res 2003, 25:180-191
6. Friedman SL: Seminars in medicine of the Beth Israel Hospital, Boston: the cellular basis of hepatic fibrosis Mechanisms and treatment strategies. N Engl J Med 1993, 328:1828-1835
7. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005, 115:209-218
8. Aldana PR, Goerke ME, Carr SC, Tracy TF Jr: The expression of regenerative growth factors in chronic liver injury and repair. J Surg Res 1994, 57:711-717
9. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ: Mechanisms of hepatotoxicity. Toxicol Sci 2002, 65:166-176
10. Gehring S, Dickson EM, San Martin ME, van Rooijen N, Papa EF, Harty MW, Tracy TF Jr, Gregory SH: Kupffer cells abrogate cholestatic liver injury in mice. Gastroenterology 2006, 130:810-822
11. Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta 2006, 364:33-60
12. Owen CA, Zhuma H, Lopez-Otin C, Shapiro SD: Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J Immunol 2004, 172:7791-7803
13. Harty MW, Papa EF, Huddleston HM, Young E, Nazareth S, Riley CA, Ramm GA, Gregory SH, Tracy TF Jr: Hepatic macrophages promote the neutrophil-dependent resolution of fibrosis in repairing cholestatic rat livers. Surgery 2008, 143:667-678
14. Harty MW, Huddleston HM, Papa EF, Puthawala T, Tracy AP, Ramm GA, Gehring S, Gregory SH, Tracy TF Jr: Repair after cholestatic liver injury correlates with neutrophil infiltration and matrix metalloproteinase 8 activity. Surgery 2005, 138:313-320
15. Gujral JS, Farhood A, Bajt ML, Jaeschke H: Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology 2003, 38:355-363
16. Svegliati-Baroni G, Ridolfi F, Caradonna Z, Alvaro D, Marzioni M, Saccomanno S, Candelaresi C, Trozzil L, Macarri G, Benedetti A, Folli F: Regulation of ERK/JNK/p70S6K in two rat models of liver injury and fibrosis. J Hepatol 2003, 39:528-537
17. Roggin KK, Papa EF, Kurkchubasche AG, Tracy TF Jr: Kupffer cell inactivation delays repair in a rat model of reversible biliary obstruction. J Surg Res 2000, 90:166-173
18. Sekiya S, Gotoh S, Yamashita T, Watanabe T, Saitoh S, Sendo F: Selective depletion of rat neutrophils by in vivo administration of a monoclonal antibody. J Leukoc Biol 1989, 46:96-102
19. Posner MC, Burt ME, Stone MD, Han BL, Warren RS, Vydelingum NA, Brennan MF: A model of reversible obstructive jaundice in the rat. J Surg Res 1990, 48:204-210
20. Moloney WC, McPherson K, Fliegelman L: Esterase activity in leukocytes demonstrated by the use of naphthol AS-D chloroacetate substrate. J Histochem Cytochem 1960, 8:200-207
21. Damoiseaux JG, Dopp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD: Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 1994, 83:140-147
22. Dijkstra CD, Dopp EA, Joling P, Kraal G: The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage sub-populations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985, 54:589-599
23. Rozen S, Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386
24. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol 2003, 38(Suppl. 1):S38-S53
25. Lewindon PJ, Pereira TN, Hoskins AC, Bridle KR, Williamson RM, Shepherd RW, Ramm GA: The role of hepatic stellate cells and transforming growth factor-β(1) in cystic fibrosis liver disease. Am J Pathol 2002, 160:1705-1715
26. Decker K: Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990, 192:245-261
27. Gaillard T, Mulsch A, Busse R, Klein H, Decker K: Regulation of nitric oxide production by stimulated rat Kupffer cells. Pathobiology 1991, 59:280-283
28. Ishizaki-Koizumi S, Sonaka I, Takei Y, Ikejima K, Sato N: The glycine analogue, aminomethanesulfonic acid, inhibits LPS-induced production of TNF-α in isolated rat Kupffer cells and exerts hepatoprotective effects in mice. Biochem Biophys Res Commun 2004, 322:514-519
29. Tracy TF, Jr., Dillon P, Fox ES, Minnick K, Vogler C: The inflammatory response in pediatric biliary disease: macrophage phenotype and distribution. J Pediatr Surg 1996, 31:121-125, discussion 125-126
30. Schaefer B, Rivas-Estilla AM, Meraz-Cruz N, Reyes-Romero MA, Hernandez-Nazara ZH, Dominguez-Rosales JA, Schuppan D, Greenwel P, Rojkind M: Reciprocal modulation of matrix metalloproteinase-13 and type I collagen genes in rat hepatic stellate cells. Am J Pathol 2003, 162:1771-1780
31. Benyon RC, Arthur MJ. Mechanisms of hepatic fibrosis. J Pediatr Gastroenterol Nutr 1998, 27:75-85
32. Ramm GA, Hoskins AC, Greco SA, Pereira TN, Lewindon PJ. Signals for hepatic figrogenesis in pediatric cholestatic liver disease: review and hypothesis. Comp Hepatol 2004, 3(Suppl. 1):S5 33. Benyon RC, Iredale JP: Is liver fibrosis reversible? Gut 2000, 46: 443-446
33. Becher N, Hein M, Uldbjerg N, Christian Danielsen C. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP. Reprod Biol Endocrinol. 2008, 30:6:45-52
34. Barrett AJ, Rawlings ND, Woessner JF (Eds). Handbook of Proteolytic Enzymes, Ed. 2. Amsterdam, The Netherlands, Elsevier Academic Press, 2004
35. Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, Iredale JP: Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 2007, 178:5288-5295